Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd1342.pdf
Reference100 articles.
1. Arend, W. P., Malyak, M., Guthridge, C. J. & Gabay, C. Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 16, 27–55 (1998).
2. Hallegua, D. S. & Weisman, M. H. Potential therapeutic uses of interleukin-1 receptor antagonists in human diseases. Ann. Rheum. Dis. 61, 960–967 (2003).
3. Cominelli, F. & Pizarro, T. T. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment. Pharmacol. Ther. 10, 49–53 (1996).
4. Rothwell, N. J. Interleukin-1 and neuronal injury: mechanisms, modification and therapeutic potential. Brain Behav. Immun. 17, 152–157 (2003).
5. Dayer, J. M. The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis. Joint Bone Spine 69, 123–132 (2002).
Cited by 204 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction;International Journal of Molecular Sciences;2024-01-20
2. Network-Based In Silico Analysis of New Combinations of Modern Drug Targets with Methotrexate for Response-Based Treatment of Rheumatoid Arthritis;Journal of Personalized Medicine;2023-10-29
3. Potential of oligonucleotide- and protein/peptide-based therapeutics in the management of toxicant/stressor-induced diseases;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-09-09
4. Expression and characterization of recombinant IL-1Ra in Aspergillus oryzae as a system;BMC Biotechnology;2023-06-20
5. Tannic acid, an IL-1β-direct binding compound, ameliorates IL-1β-induced inflammation and cartilage degradation by hindering IL-1β-IL-1R1 interaction;PLOS ONE;2023-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3